Samsung C&T: Share Price Down 14.3% in a Month as Profits Grow and a Rights Offering Appears in Filings

Thesis

The data supports a picture of improving profitability. Operating margin rose from 3.5% in 2021 to 8.2% on a trailing basis, and net income grew from ₩1.6T in 2021 to ₩2.8T over the trailing twelve months to H1 2026. Free cash flow of ₩3.8T and cash of ₩4.9T against borrowings of ₩1.8T point to a solid financial position.

What the data does not support is a clear explanation for the recent share price decline. No news headlines are available, and investor flow, foreign ownership and short balance data are all missing. The shares sit 44.3% below the 52-week high of ₩565,000 but well above the low of ₩193,300. Returns on equity have drifted down, from 7.3% in 2023 to 6.0% in 2025 and 4.1% on a trailing basis, even as profits rose, which suggests equity is growing faster than earnings. The rights offering filings are a notable item, but the data gives no size, purpose or terms.

Business overview

Samsung C&T is listed on KOSPI and classified in the Retail & Trade sector. It was founded on 1963-12-23 and listed on 2014-12-18, with 169,976,544 listed shares. Market capitalization is about ₩53.5T. The data lists the CEOs as 오세철, 이재언 and 송규종. Revenue has ranged between ₩34.5T in 2021 and ₩43.4T on a trailing basis, with a jump of 25.3% in 2022 followed by roughly flat to slightly lower years. The listed peers by market cap (POSCO International ₩9.6T, ISC ₩4.1T, Youngone ₩3.2T, Shinsegae ₩2.9T, Lotte Shopping ₩2.8T) are all far smaller. The data does not describe segments or products.

Financial analysis

All figures below come from filed financial statements (DART), consolidated where available.

Trailing twelve months to H1 2026: revenue ₩43.4T, operating income ₩3.6T, net income ₩2.8T, giving an operating margin of 8.2% and a net margin of 6.4%. ROE is 4.1%.

Annual trend: revenue was ₩40.7T in 2025 (down 3.2%), ₩42.1T in 2024 (up 0.5%), ₩41.9T in 2023 (down 2.9%) and ₩43.2T in 2022 (up 25.3%). Operating income rose each year, from ₩1.2T in 2021 to ₩3.3T in 2025. Operating margin moved from 3.5% to 5.9%, 6.9%, 7.1% and 8.1% over 2021 to 2025. Net income rose from ₩1.6T to ₩2.4T over the same span.

Balance sheet and cash flow: liabilities to equity are 44.0%, cash is ₩4.9T, borrowings are ₩1.8T and free cash flow is ₩3.8T.

Valuation

At the current price the P/E is 19.1, the P/B is 0.5, the P/S is 1.2 and the dividend yield is 0.9%. Enterprise value is about ₩50.4T. EV/EBITDA is not available.

Against its own history, the only comparison point is year-end 2025, when P/E was 16.7 and P/B was 0.8. The P/E is therefore higher now, while the P/B is lower. Earlier year-end multiples are not available. Peer P/E and P/B figures are not available in the data, so a peer valuation comparison cannot be made.

Catalysts

• A rights offering (paid-in capital increase) decision was filed on 2026-08-28 and amended on 2026-10-01, though the data gives no terms.
• A change in the largest shareholder's holdings was filed on 2026-09-28.
• A filing on 2026-09-21 described a major management matter relevant to investors, with no detail in the data.
• Major sales or supply contract filings appeared on 2026-08-31 and were amended on 2026-09-18.
• Investor relations events were held on 2026-09-04, 2026-09-09 and 2026-09-18, and an amended share acquisition filing dated 2026-08-28 is also on record.

Risks

• The share price has fallen 14.3% in one month and sits 44.3% below its 52-week high, showing high recent volatility.
• The rights offering could add to the share count, but its size and terms are not in the data.
• ROE has declined from 7.3% in 2023 to 4.1% on a trailing basis, indicating lower returns on a growing equity base.
• Revenue has been flat to lower since the 2022 peak of ₩43.2T, so profit growth has relied on margin gains.
• Investor flow, foreign ownership, short balance and news data are unavailable, which limits visibility into what is driving the price.

Closing view

The filed numbers show a company with rising margins, large cash generation and moderate leverage, while the shares trade at 0.5 times book value and 19.1 times earnings. Set against that are a sharp one-month price drop, declining ROE, flat revenue and a rights offering whose details are not in the data. With flows, peer multiples and news unavailable, the evidence is mixed and incomplete, and the reasons behind the recent price move cannot be established from this data alone.

Model estimate of fair value

The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).

Report history

1. Oct 13, 2026InitiationSamsung C&T: Share Price Down 14.3% in a Month as Profits Grow and a Rights Offering Appears in Filings